Extraction and Visualization of Protein Aggregates after Treatment of Escherichia coli with a Proteotoxic Stressor
June 29th, 2021
This protocol describes the extraction and visualization of aggregated and soluble proteins from Escherichia coli after treatment with a proteotoxic antimicrobial. Following this procedure allows a qualitative comparison of protein aggregate formation in vivo in different bacterial strains and/or between treatments.
Overview
This protocol describes a method for extracting and visualizing protein aggregates from Escherichia coli after exposure to a proteotoxic antimicrobial. It allows for qualitative comparisons of protein aggregation across different bacterial strains and treatments.
Key Study Components
Area of Science
- Microbiology
- Protein Aggregation
- Antimicrobial Resistance
Background
- Stress can induce protein aggregation in bacteria.
- Protein aggregation can significantly alter bacterial phenotypes.
- This protocol is simpler than existing methods, requiring fewer cells.
- It avoids complicated physical disruption and lengthy washing steps.
Purpose of Study
- To extract and visualize protein aggregates in bacteria.
- To compare protein aggregation between different bacterial strains.
- To analyze the effects of gene deletions and proteotoxic compounds.
Methods Used
- Inoculation of E. coli strains MG1655 and CFT073 in LB medium.
- Extraction of soluble and aggregated proteins post-treatment.
- Visualization of protein aggregates.
- Qualitative comparison of results across strains and treatments.
Main Results
- Successful extraction of protein aggregates from treated E. coli.
- Demonstrated differences in aggregation between strains.
- Provided insights into the effects of proteotoxic stress.
- Enabled analysis of gene deletions on protein aggregation.
Conclusions
- This protocol is efficient for studying protein aggregation.
- It can be applied to various gram-negative and gram-positive bacteria.
- It simplifies the process of analyzing protein aggregates in bacterial research.
Frequently Asked Questions
Executive Industry Relevance
Protein aggregation under proteotoxic stress is a critical challenge in microbial strain engineering and antimicrobial discovery. This extraction and visualization protocol enables rapid, comparative assessment of aggregation phenotypes across bacterial strains, supporting early-stage target validation and mechanistic de-risking. The method's scalability and simplicity facilitate integration into discovery pipelines evaluating proteostasis modulators and antimicrobial candidates.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of proteostasis pathways and stress response mechanisms in bacteria.
- Supports functional validation of genetic targets influencing aggregation phenotypes.
- Facilitates mechanistic de-risking by distinguishing compound-specific aggregation effects.
- Provides comparative data for prioritizing strain or target selection in antimicrobial programs.
Screening & Assay Development
- Prepares validated bacterial systems for downstream screening of proteotoxic compounds.
- Delivers reproducible, qualitative aggregation readouts for assay standardization.
- Enables rapid comparison of compound efficacy and genetic perturbations on aggregation.
- Supports platform reuse across diverse bacterial strains and stressors.
Translational & Preclinical Research
- Aligns with translational biomarker strategies by linking aggregation to phenotypic outcomes.
- Provides continuity from discovery to preclinical validation of antimicrobial mechanisms.
- Informs risk-adjusted advancement of compounds targeting bacterial proteostasis.
- Offers predictive de-risking for compounds with aggregation-related liabilities.
Pipeline & Workflow Integration
This protocol fits within the early discovery to lead identification continuum, enabling hypothesis testing and mechanistic evaluation of proteotoxic stress responses in bacteria.
- Discovery Biology: Supports hypothesis-driven analysis of aggregation pathways and genetic determinants.
- Screening: Provides reproducible aggregation readouts for compound and genetic screens.
- Analytics: Delivers qualitative and semi-quantitative gel-based outputs for condition comparison.
- Translational Research: Bridges discovery findings to preclinical models by linking aggregation to phenotypic shifts.
- Enterprise Reuse: Adaptable across bacterial species and stressors for broad R&D applicability.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and mechanistic studies.
- Operational Value: Streamlines workflows with reduced cell input and simplified processing.
- Strategic Value: Enables informed go/no-go decisions for antimicrobial and proteostasis-targeting programs.
- Portfolio Impact: Supports risk-adjusted prioritization of compounds and genetic targets.
Implementation Considerations
- Requires expertise in bacterial culture, protein extraction, and gel electrophoresis.
- Needs access to centrifugation, SDS-PAGE, and staining infrastructure.
- Standardization of OD600 normalization is critical for cross-sample comparison.
- Protocol is adaptable to various bacterial strains and proteotoxic agents.
- Qualitative outputs may require complementary quantitative assays for advanced analytics.
Biopharma FAQs
Chapters in this video
0:05
Introduction
0:53
Stress Treatment of E. coli Strains MG1655 and CFT073
2:12
Collecting Bacterial Cell Samples
2:43
Extracting the Insoluble Protein Aggregates
4:19
Soluble Protein Sample Preparation
5:30
Separation and Visualization of Extracted Protein Aggregates Using SDS-PAGE
6:49
Results: Visualization of Protein Aggregates After Treatment of Escherichia coli with a Proteotoxic Stressor
7:32
Conclusion
